Details checkedClinical trial listing onlyCheckedregistry+company

Blackrock NeuroPort BCI System

Also known as: NeuroPort Array, NeuroPort Electrode 96, Utah Array, Blackrock NeuroPort

Blackrock Neurotech

Primary source

Company

Blackrock Neurotech

Program Type

Software/Neurotech

Modality

BCI/Neurotech

Stage

Marketed

Status

Marketed

Target Gene

—

Route / Mode

Intracortical microelectrode array plus neural signal processor and research/clinical software stack

Confidence

90%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States, Global

Population

adult, implantable-bci, intracortical-interface, research-platform, assistive-technology, communication-accessibility

Trial IDs

Mechanism

Intracortical neural interface and recording system centered on the NeuroPort electrode array and neural signal processor, used in human BCI research for cursor, robotic, sensory-feedback, and assistive communication control.

Indications

Communication Impairment Severe Paralysis Speech Impairment

Notes

Foundational clinical/research BCI platform. Included to represent the long-running intracortical NeuroPort/Utah Array lineage underlying many communication and assistive-control milestones, without implying a consumer hearing-loss product.

Evidence & Sources

4 structured sources

company

Supports: canonicalName, company, mechanism, status, route

Open

company

Supports: aliases, mechanism, route, populationTags

Open

clinicaltrials

Supports: trialIds, indications

IDs: NCT00912041

Open